Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study
Go back to Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 65.79 -4.88 (6.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $70.67 | 52 Week High | $8.22 | |||
| Open | $70.41 | 52 Week Low | $3.07 | |||
| Day High | $71.93 | P/E | N/A | |||
| Day Low | $64.50 | EPS | $-1.30 | |||
| Volume | 5,112,413 | |||||
